Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Sep 1;102(5):919–928. doi: 10.1172/JCI307

Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.

D J Pinsky 1, H Liao 1, C A Lawson 1, S F Yan 1, J Chen 1, P Carmeliet 1, D J Loskutoff 1, D M Stern 1
PMCID: PMC508957  PMID: 9727060

Abstract

Oxygen deprivation, as occurs during tissue ischemia, tips the natural anticoagulant/procoagulant balance of the endovascular wall to favor activation of coagulation. To investigate the effects of low ambient oxygen tension on the fibrinolytic system, mice were placed in a hypoxic environment with pO2 < 40 Torr. Plasma levels of plasminogen activator inhibitor-1 (PAI-1) antigen, detected by ELISA, increased in a time-dependent fashion after hypoxic exposure (increased as early as 4 h, P < 0.05 vs. normoxic controls), and were accompanied by an increase in plasma PAI-1 activity by 4 h (P < 0.05 vs. normoxic controls). Northern analysis of hypoxic murine lung demonstrated an increase in PAI-1 mRNA compared with normoxic controls; in contrast, transcripts for both tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) decreased under hypoxic conditions. Immunocolocalization studies identified macrophages as the predominant source of increased PAI-1 within hypoxic lung. Using a transformed murine macrophage line, striking induction of PAI-1 transcripts occurred under hypoxic conditions, due to both increased de novo transcription as well as increased mRNA stability. Consistent with an important role of the fibrinolytic system in hypoxia-induced fibrin accumulation, PAI-1 +/+ mice exposed to hypoxia exhibited increased pulmonary fibrin deposition based upon a fibrin immunoblot, intravascular fibrin identified by immunostaining, and increased accumulation of 125I-fibrinogen/fibrin in hypoxic tissue. In contrast, mice deficient for the PAI-1 gene (PAI-1 -/-) similarly exposed to hypoxic conditions did not display increased fibrin accumulation compared with normoxic PAI-1 +/+ controls. Furthermore, homozygous null uPA (uPA -/-) and tPA (tPA -/-) mice subjected to oxygen deprivation showed increased fibrin deposition compared with wild-type controls. These studies identify enhanced expression of PAI-1 as an important mechanism suppressing fibrinolysis under conditions of low oxygen tension, a response which may be further amplified by decreased expression of plasminogen activators. Taken together, these data provide insight into an important potential role of macrophages and the fibrinolytic system in ischemia-induced thrombosis.

Full Text

The Full Text of this article is available as a PDF (4.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bacharach E., Itin A., Keshet E. In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogenesis. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10686–10690. doi: 10.1073/pnas.89.22.10686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bevilacqua M. P., Pober J. S., Majeau G. R., Cotran R. S., Gimbrone M. A., Jr Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med. 1984 Aug 1;160(2):618–623. doi: 10.1084/jem.160.2.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bevilacqua M. P., Schleef R. R., Gimbrone M. A., Jr, Loskutoff D. J. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest. 1986 Aug;78(2):587–591. doi: 10.1172/JCI112613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bärtsch P., Haeberli A., Hauser K., Gubser A., Straub P. W. Fibrinogenolysis in the absence of fibrin formation in severe hypobaric hypoxia. Aviat Space Environ Med. 1988 May;59(5):428–432. [PubMed] [Google Scholar]
  5. Carmeliet P., Kieckens L., Schoonjans L., Ream B., van Nuffelen A., Prendergast G., Cole M., Bronson R., Collen D., Mulligan R. C. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest. 1993 Dec;92(6):2746–2755. doi: 10.1172/JCI116892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carmeliet P., Schoonjans L., Kieckens L., Ream B., Degen J., Bronson R., De Vos R., van den Oord J. J., Collen D., Mulligan R. C. Physiological consequences of loss of plasminogen activator gene function in mice. Nature. 1994 Mar 31;368(6470):419–424. doi: 10.1038/368419a0. [DOI] [PubMed] [Google Scholar]
  7. Carmeliet P., Stassen J. M., Schoonjans L., Ream B., van den Oord J. J., De Mol M., Mulligan R. C., Collen D. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest. 1993 Dec;92(6):2756–2760. doi: 10.1172/JCI116893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chapman H. A., Yang X. L., Sailor L. Z., Sugarbaker D. J. Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages. Possible role in lung injury. J Immunol. 1990 Nov 15;145(10):3398–3405. [PubMed] [Google Scholar]
  9. Collen D., Lijnen H. R. Fibrin-specific fibrinolysis. Ann N Y Acad Sci. 1992 Dec 4;667:259–271. doi: 10.1111/j.1749-6632.1992.tb51623.x. [DOI] [PubMed] [Google Scholar]
  10. Emeis J. J., Hoekzema R., de Vos A. F. Inhibiting interleukin-1 and tumor necrosis factor-alpha does not reduce induction of plasminogen activator inhibitor type-1 by endotoxin in rats in vivo. Blood. 1995 Jan 1;85(1):115–120. [PubMed] [Google Scholar]
  11. Emeis J. J., Lindeman J., Nieuwenhuizen W. Immunoenzyme histochemical localization of fibrin degradation products in tissues. Am J Pathol. 1981 Jun;103(3):337–344. [PMC free article] [PubMed] [Google Scholar]
  12. Francis C. W., Marder V. J., Martin S. E. Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complexes. Blood. 1980 Sep;56(3):456–464. [PubMed] [Google Scholar]
  13. Gertler J. P., Perry L., L'Italien G., Chung-Welch N., Cambria R. P., Orkin R., Abbott W. M. Ambient oxygen tension modulates endothelial fibrinolysis. J Vasc Surg. 1993 Dec;18(6):939–946. [PubMed] [Google Scholar]
  14. Hamer J. D., Malone P. C., Silver I. A. The PO2 in venous valve pockets: its possible bearing on thrombogenesis. Br J Surg. 1981 Mar;68(3):166–170. doi: 10.1002/bjs.1800680308. [DOI] [PubMed] [Google Scholar]
  15. Ito K., Ryuto M., Ushiro S., Ono M., Sugenoya A., Kuraoka A., Shibata Y., Kuwano M. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel. J Cell Physiol. 1995 Feb;162(2):213–224. doi: 10.1002/jcp.1041620207. [DOI] [PubMed] [Google Scholar]
  16. Karakurum M., Shreeniwas R., Chen J., Pinsky D., Yan S. D., Anderson M., Sunouchi K., Major J., Hamilton T., Kuwabara K. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J Clin Invest. 1994 Apr;93(4):1564–1570. doi: 10.1172/JCI117135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kassis J., Hirsh J., Podor T. J. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood. 1992 Oct 1;80(7):1758–1764. [PubMed] [Google Scholar]
  18. Koga S., Morris S., Ogawa S., Liao H., Bilezikian J. P., Chen G., Thompson W. J., Ashikaga T., Brett J., Stern D. M. TNF modulates endothelial properties by decreasing cAMP. Am J Physiol. 1995 May;268(5 Pt 1):C1104–C1113. doi: 10.1152/ajpcell.1995.268.5.C1104. [DOI] [PubMed] [Google Scholar]
  19. Koga S., Ogawa S., Kuwabara K., Brett J., Leavy J. A., Ryan J., Koga Y., Plocinski J., Benjamin W., Burns D. K. Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J Clin Invest. 1992 Sep;90(3):1007–1015. doi: 10.1172/JCI115913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kourembanas S., Marsden P. A., McQuillan L. P., Faller D. V. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991 Sep;88(3):1054–1057. doi: 10.1172/JCI115367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kuwabara K., Ogawa S., Matsumoto M., Koga S., Clauss M., Pinsky D. J., Lyn P., Leavy J., Witte L., Joseph-Silverstein J. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A. 1995 May 9;92(10):4606–4610. doi: 10.1073/pnas.92.10.4606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Lahiri B., Koehn J. A., Canfield R. E., Birken S., Lewis J. Development of an immunoassay for the COOH-terminal region of the gamma chains of human fibrin. Thromb Res. 1981 Jul 1;23(1-2):103–112. doi: 10.1016/0049-3848(81)90243-7. [DOI] [PubMed] [Google Scholar]
  23. Lawson C. A., Yan S. D., Yan S. F., Liao H., Zhou Y. S., Sobel J., Kisiel W., Stern D. M., Pinsky D. J. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest. 1997 Apr 1;99(7):1729–1738. doi: 10.1172/JCI119337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lee S. H., Starkey P. M., Gordon S. Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med. 1985 Mar 1;161(3):475–489. doi: 10.1084/jem.161.3.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Loskutoff D. J., Sawdey M., Keeton M., Schneiderman J. Regulation of PAI-1 gene expression in vivo. Thromb Haemost. 1993 Jul 1;70(1):135–137. [PubMed] [Google Scholar]
  26. Loskutoff D. J., Sawdey M., Mimuro J. Type 1 plasminogen activator inhibitor. Prog Hemost Thromb. 1989;9:87–115. [PubMed] [Google Scholar]
  27. MacGregor I. R., Booth N. A. An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1). Thromb Haemost. 1988 Feb 25;59(1):68–72. [PubMed] [Google Scholar]
  28. Mangum M., Venable R. H., Boatwright J. D., Cocke T. B. Hypoxia: a stimulus for tissue plasminogen activator release in humans? Aviat Space Environ Med. 1987 Nov;58(11):1093–1096. [PubMed] [Google Scholar]
  29. Martin N. B., Jamieson A., Tuffin D. P. The effect of interleukin-4 on tumour necrosis factor-alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Thromb Haemost. 1993 Dec 20;70(6):1037–1042. [PubMed] [Google Scholar]
  30. Nachman R. L., Hajjar K. A., Silverstein R. L., Dinarello C. A. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med. 1986 Jun 1;163(6):1595–1600. doi: 10.1084/jem.163.6.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nawroth P. P., Stern D. M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986 Mar 1;163(3):740–745. doi: 10.1084/jem.163.3.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nossel H. L. Relative proteolysis of the fibrinogen B beta chain by thrombin and plasmin as a determinant of thrombosis. Nature. 1981 May 14;291(5811):165–167. doi: 10.1038/291165a0. [DOI] [PubMed] [Google Scholar]
  33. Ogawa S., Gerlach H., Esposito C., Pasagian-Macaulay A., Brett J., Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest. 1990 Apr;85(4):1090–1098. doi: 10.1172/JCI114540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ogawa S., Shreeniwas R., Brett J., Clauss M., Furie M., Stern D. M. The effect of hypoxia on capillary endothelial cell function: modulation of barrier and coagulant function. Br J Haematol. 1990 Aug;75(4):517–524. doi: 10.1111/j.1365-2141.1990.tb07792.x. [DOI] [PubMed] [Google Scholar]
  35. Padró T., Quax P. H., van den Hoogen C. M., Roholl P., Verheijen J. H., Emeis J. J. Tissue-type plasminogen activator and its inhibitor in rat aorta. Effect of endotoxin. Arterioscler Thromb. 1994 Sep;14(9):1459–1465. doi: 10.1161/01.atv.14.9.1459. [DOI] [PubMed] [Google Scholar]
  36. Pinsky D. J., Naka Y., Liao H., Oz M. C., Wagner D. D., Mayadas T. N., Johnson R. C., Hynes R. O., Heath M., Lawson C. A. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest. 1996 Jan 15;97(2):493–500. doi: 10.1172/JCI118440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pinsky D. J., Oz M. C., Koga S., Taha Z., Broekman M. J., Marcus A. J., Liao H., Naka Y., Brett J., Cannon P. J. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest. 1994 May;93(5):2291–2297. doi: 10.1172/JCI117230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pinsky D. J., Yan S. F., Lawson C., Naka Y., Chen J. X., Connolly E. S., Jr, Stern D. M. Hypoxia and modification of the endothelium: implications for regulation of vascular homeostatic properties. Semin Cell Biol. 1995 Oct;6(5):283–294. doi: 10.1006/scel.1995.0038. [DOI] [PubMed] [Google Scholar]
  39. Pralong G., Calandra T., Glauser M. P., Schellekens J., Verhoef J., Bachmann F., Kruithof E. K. Plasminogen activator inhibitor 1: a new prognostic marker in septic shock. Thromb Haemost. 1989 Jun 30;61(3):459–462. [PubMed] [Google Scholar]
  40. Quax P. H., van den Hoogen C. M., Verheijen J. H., Padro T., Zeheb R., Gelehrter T. D., van Berkel T. J., Kuiper J., Emeis J. J. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem. 1990 Sep 15;265(26):15560–15563. [PubMed] [Google Scholar]
  41. Rickles R. J., Darrow A. L., Strickland S. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. J Biol Chem. 1988 Jan 25;263(3):1563–1569. [PubMed] [Google Scholar]
  42. Risberg B., Stenberg B. Modulation of tissue fibrinolysis from hypoxia and hyperoxia. Thromb Res. 1985 Apr 15;38(2):129–136. doi: 10.1016/0049-3848(85)90055-6. [DOI] [PubMed] [Google Scholar]
  43. Rånby M., Norrman B., Wallén P. A sensitive assay for tissue plasminogen activator. Thromb Res. 1982 Sep 15;27(6):743–749. doi: 10.1016/0049-3848(82)90012-3. [DOI] [PubMed] [Google Scholar]
  44. Schneiderman J., Eguchi Y., Adar R., Sawdey M. Modulation of the fibrinolytic system by major peripheral ischemia. J Vasc Surg. 1994 Mar;19(3):516–524. doi: 10.1016/s0741-5214(94)70080-x. [DOI] [PubMed] [Google Scholar]
  45. Shatos M. A., Doherty J. M., Orfeo T., Hoak J. C., Collen D., Stump D. C. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals. J Biol Chem. 1992 Jan 5;267(1):597–601. [PubMed] [Google Scholar]
  46. Shatos M. A., Doherty J. M., Stump D. C., Thompson E. A., Collen D. Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture. J Biol Chem. 1990 Nov 25;265(33):20443–20448. [PubMed] [Google Scholar]
  47. Shreeniwas R., Koga S., Karakurum M., Pinsky D., Kaiser E., Brett J., Wolitzky B. A., Norton C., Plocinski J., Benjamin W. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 1992 Dec;90(6):2333–2339. doi: 10.1172/JCI116122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tappy L., Hauert J., Bachmann F. Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system. Thromb Res. 1984 Jan 15;33(2):117–124. doi: 10.1016/0049-3848(84)90172-5. [DOI] [PubMed] [Google Scholar]
  49. Wiman B., Mellbring G., Rånby M. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay. Clin Chim Acta. 1983 Jan 24;127(2):279–288. doi: 10.1016/s0009-8981(83)80012-6. [DOI] [PubMed] [Google Scholar]
  50. Yamamoto C., Kaji T., Sakamoto M., Kozuka H., Koizumi F. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells. Thromb Res. 1994 Apr 15;74(2):163–168. doi: 10.1016/0049-3848(94)90009-4. [DOI] [PubMed] [Google Scholar]
  51. Yamamoto K., Loskutoff D. J. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest. 1996 Jun 1;97(11):2440–2451. doi: 10.1172/JCI118691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yan S. F., Tritto I., Pinsky D., Liao H., Huang J., Fuller G., Brett J., May L., Stern D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem. 1995 May 12;270(19):11463–11471. doi: 10.1074/jbc.270.19.11463. [DOI] [PubMed] [Google Scholar]
  53. van Hinsbergh V. W., Kooistra T., van den Berg E. A., Princen H. M., Fiers W., Emeis J. J. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood. 1988 Nov;72(5):1467–1473. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES